Microbot Medical (MBOT) Gains from Investment Securities (2016)
Historic Gains from Investment Securities for Microbot Medical (MBOT) over the last 7 years, with Q4 2016 value amounting to $1.3 million.
- Microbot Medical's Gains from Investment Securities rose 96100.26% to $1.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$262000.0, marking a year-over-year increase of 8317.31%. This contributed to the annual value of $98000.0 for FY2024, which is 9600.0% up from last year.
- Latest data reveals that Microbot Medical reported Gains from Investment Securities of $1.3 million as of Q4 2016, which was up 96100.26% from $4.3 million recorded in Q3 2016.
- In the past 5 years, Microbot Medical's Gains from Investment Securities ranged from a high of $11.2 million in Q3 2012 and a low of -$6.2 million during Q2 2012
- In the last 5 years, Microbot Medical's Gains from Investment Securities had a median value of $326624.0 in 2014 and averaged $585649.8.
- As far as peak fluctuations go, Microbot Medical's Gains from Investment Securities plummeted by 294045.13% in 2014, and later skyrocketed by 96100.26% in 2016.
- Quarter analysis of 5 years shows Microbot Medical's Gains from Investment Securities stood at -$4.0 million in 2012, then skyrocketed by 170.17% to $2.8 million in 2013, then fell by 17.72% to $2.3 million in 2014, then crashed by 106.66% to -$155000.0 in 2015, then soared by 961.0% to $1.3 million in 2016.
- Its last three reported values are $1.3 million in Q4 2016, $4.3 million for Q3 2016, and -$5.6 million during Q2 2016.